The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,4-Dibromo-5-(5-(4-(p-tolyloxy)phenyl)oxazol-2-yl)benzene-1,2-diol ID: ALA4513341
PubChem CID: 155538861
Max Phase: Preclinical
Molecular Formula: C22H15Br2NO4
Molecular Weight: 517.17
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(Oc2ccc(-c3cnc(-c4cc(O)c(O)c(Br)c4Br)o3)cc2)cc1
Standard InChI: InChI=1S/C22H15Br2NO4/c1-12-2-6-14(7-3-12)28-15-8-4-13(5-9-15)18-11-25-22(29-18)16-10-17(26)21(27)20(24)19(16)23/h2-11,26-27H,1H3
Standard InChI Key: RWNXHFJDYZGYKR-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
30.8758 -19.7860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6930 -19.7860 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9473 -19.0093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2844 -18.5271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6256 -19.0093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7211 -18.7564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3276 -19.3058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1045 -19.0549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2761 -18.2551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6647 -17.7065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8901 -17.9603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8505 -18.7597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6813 -17.9590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9048 -17.7068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2969 -18.2541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4706 -19.0570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2468 -19.3055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8329 -16.9068 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.0533 -18.0026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.7108 -19.6029 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
27.5192 -18.0030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.3479 -17.2039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9562 -16.6591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7854 -15.8608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0070 -15.6089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3993 -16.1616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5733 -16.9579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1557 -20.1047 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
26.8347 -14.8101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
3 6 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
5 12 1 0
10 18 1 0
9 19 1 0
8 20 1 0
15 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
7 28 1 0
25 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 517.17Molecular Weight (Monoisotopic): 514.9368AlogP: 7.05#Rotatable Bonds: 4Polar Surface Area: 75.72Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.87CX Basic pKa: 0.50CX LogP: 6.45CX LogD: 5.82Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.28Np Likeness Score: -0.09
References 1. Li X, Xu Q, Li C, Luo J, Li X, Wang L, Jiang B, Shi D.. (2019) Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors., 166 [PMID:30711829 ] [10.1016/j.ejmech.2019.01.057 ]